Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Establishment Labs Holdings Inc.

< Previous 1 2 3 Next >
Establishment Labs to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From Establishment Labs Holdings Inc.
Via Business Wire
Tickers ESTA
Establishment Labs Announces Participation in Two Upcoming Investment Conferences
From Establishment Labs Holdings Inc.
Via Business Wire
Tickers ESTA
Establishment Labs Announces National Medical Products Administration Approval for Motiva Implants in China
From Establishment Labs Holdings Inc.
Via Business Wire
Tickers ESTA
Establishment Labs Reports Third Quarter 2023 Financial Results
From Establishment Labs Holdings Inc.
Via Business Wire
Tickers ESTA
Establishment Labs to Announce Third Quarter 2023 Financial Results on November 7
From Establishment Labs Holdings Inc.
Via Business Wire
Tickers ESTA
Establishment Labs Announces FDA Clearance of Motiva Flora SmoothSilk Tissue Expander
From Establishment Labs Holdings Inc.
Via Business Wire
Tickers ESTA
Establishment Labs Announces Two-Year Mia Femtech Clinical Results and the Launch of Zen at 8th World Symposium on Ergonomic Implants
From Establishment Labs Holdings Inc.
Via Business Wire
Tickers ESTA
Establishment Labs Reports Record Second Quarter 2023 Financial Results
From Establishment Labs Holdings Inc.
Via Business Wire
Tickers ESTA
Establishment Labs to Announce Second Quarter 2023 Financial Results on August 8
From Establishment Labs Holdings Inc.
Via Business Wire
Tickers ESTA
Establishment Labs Celebrates Opening of Sulàyöm Innovation Campus and Outlines New and Expanded Capabilities
From Establishment Labs Holdings Inc.
Via Business Wire
Tickers ESTA
Establishment Labs to Participate in Two Upcoming Investor Conferences
From Establishment Labs Holdings Inc.
Via Business Wire
Tickers ESTA
Establishment Labs Announces CE Mark Approval for Minimally Invasive Surgical Tools
From Establishment Labs Holdings Inc.
Via Business Wire
Tickers ESTA
Establishment Labs Reports Record First Quarter 2023 Financial Results
From Establishment Labs Holdings Inc.
Via Business Wire
Tickers ESTA
Establishment Labs Announces Closing of Public Offering of Common Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares
From Establishment Labs Holdings Inc.
Via Business Wire
Tickers ESTA
Establishment Labs to Announce First Quarter 2023 Financial Results on May 8
From Establishment Labs Holdings Inc.
Via Business Wire
Tickers ESTA
Establishment Labs Announces Pricing of Public Offering of Common Shares
From Establishment Labs Holdings Inc.
Via Business Wire
Tickers ESTA
Establishment Labs Announces Proposed Public Offering of Common Shares
From Establishment Labs Holdings Inc.
Via Business Wire
Tickers ESTA
Establishment Labs Announces Preliminary Unaudited Results for First Quarter 2023
From Establishment Labs Holdings Inc.
Via Business Wire
Tickers ESTA
Establishment Labs Notes Presentation of 3-Year Results from Motiva U.S. IDE Study at The Aesthetic Meeting 2023
From Establishment Labs Holdings Inc.
Via Business Wire
Tickers ESTA
Establishment Labs Begins a New Era in Breast Aesthetics with Launch of Mia Femtech in Japan
From Establishment Labs Holdings Inc.
Via Business Wire
Tickers ESTA
Establishment Labs Announces Participation in The Aesthetic Meeting 2023
From Establishment Labs Holdings Inc.
Via Business Wire
Tickers ESTA
Establishment Labs Surpasses Three Million Motiva Devices
From Establishment Labs Holdings Inc.
Via Business Wire
Tickers ESTA
Establishment Labs Announces First Mia Femtech™ Partners in Europe and Second Partner Chain in Japan
From Establishment Labs Holdings Inc.
Via Business Wire
Tickers ESTA
Establishment Labs to Present at the Cowen 43rd Annual Health Care Conference
From Establishment Labs Holdings Inc.
Via Business Wire
Tickers ESTA
Establishment Labs Submits Module Four to U.S. FDA for Premarket Approval of Motiva and Reports Record Fourth Quarter and Full Year 2022 Financial Results
From Establishment Labs Holdings Inc.
Via Business Wire
Tickers ESTA
Establishment Labs to Announce Fourth Quarter 2022 Financial Results on February 27
From Establishment Labs Holdings Inc.
Via Business Wire
Tickers ESTA
Establishment Labs Announces Preliminary Unaudited Revenue for Fourth Quarter and Fiscal Year 2022
From Establishment Labs Holdings Inc.
Via Business Wire
Tickers ESTA
Establishment Labs Announces Seishin Plastic and Aesthetic Surgery Clinic in Japan as First Clinic Partner in Global Launch of Mia Femtech™
From Establishment Labs Holdings Inc.
Via Business Wire
Tickers ESTA
Establishment Labs to Participate in 41st Annual J.P. Morgan Healthcare Conference
From Establishment Labs Holdings Inc.
Via Business Wire
Tickers ESTA
Establishment Labs Announces Japanese Regulatory Approval and Reimbursement for Motiva Implants and the Motiva Flora Tissue Expander for Use in Post-Mastectomy Reconstruction
From Establishment Labs Holdings Inc.
Via Business Wire
Tickers ESTA
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.